Laboratorios Farmaceuticos Rovi
ROVI.MC
#3634
Rank
HK$27.83 B
Marketcap
HK$544.27
Share price
0.42%
Change (1 day)
6.98%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2025 (TTM): HK$2.14 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are HK$1.05 Billion. In 2024 the company made an earning of HK$2.25 Billion a decrease over its 2023 earnings that were of HK$2.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$2.14 B-4.91%
2024 HK$2.25 B-8.41%
2023 HK$2.46 B15.62%
2022 HK$2.13 B29.09%
2021 HK$1.65 B149.21%
2020 HK$0.66 B79.92%
2019 HK$0.36 B128.6%
2018 HK$0.16 B0.14%
2017 HK$0.16 B-35.41%
2016 HK$0.24 B28.52%
2015 HK$0.19 B-32.56%
2014 HK$0.28 B8.45%
2013 HK$0.26 B-4.24%
2012 HK$0.27 B2.62%
2011 HK$0.26 B-3.29%
2010 HK$0.27 B